These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20175794)

  • 1. The hospital pharmacist: an integral part of the hyperglycaemic management team.
    Szumita PM
    J Clin Pharm Ther; 2009 Dec; 34(6):613-21. PubMed ID: 20175794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia management using insulin in the acute care setting: therapies and strategies for care in the non-critically ill patient.
    Kirk JK; Oldham EC
    Ann Pharmacother; 2010; 44(7-8):1222-30. PubMed ID: 20571106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist roles in the management of patients with type 2 diabetes.
    Sisson E; Kuhn C
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S41-5. PubMed ID: 19801364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review.
    Ponniah A; Anderson B; Shakib S; Doecke CJ; Angley M
    J Clin Pharm Ther; 2007 Aug; 32(4):343-52. PubMed ID: 17635336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A primer on critical care pharmacy services.
    Erstad BL
    Ann Pharmacother; 2008 Dec; 42(12):1871-81. PubMed ID: 19017823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and pharmacists' acceptance of a community hospital's anticoagulation management service utilizing decentralized clinical staff pharmacists.
    Airee A; Guirguis AB; Mohammad RA
    Ann Pharmacother; 2009 Apr; 43(4):621-8. PubMed ID: 19318602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of the pharmacist's expanding role on the diabetes team: reinforcing nutritional guidelines for improved glycemic control.
    Johnson LC; Beach E
    Pharm Pract Manag Q; 1997 Oct; 17(3):32-44. PubMed ID: 10173309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of diabetes in the hospital.
    Fonseca V
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S10-7. PubMed ID: 17224872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of clinical pharmacist in a cardiac-surgery intensive care unit.
    Al-Jazairi AS; Al-Agil AA; Asiri YA; Al-Kholi TA; Akhras NS; Horanieh BK
    Saudi Med J; 2008 Feb; 29(2):277-81. PubMed ID: 18246241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical services provided by staff pharmacists in a community hospital.
    Garrelts JC; Smith DF
    Am J Hosp Pharm; 1990 Sep; 47(9):2011-5. PubMed ID: 2244945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provision of pharmaceutical care in the intensive care unit.
    Kilroy RA; Iafrate RP
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):221-5. PubMed ID: 8398030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of a clinical pharmacist on a neurosurgical team.
    Weant KA; Armitstead JA; Ladha AM; Sasaki-Adams D; Hadar EJ; Ewend MG
    Neurosurgery; 2009 Nov; 65(5):946-50; discussion 950-1. PubMed ID: 19834408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of a pharmacist in improving rational drug therapy as part of the patient care team.
    Smith WE
    Ann Pharmacother; 2007 Feb; 41(2):330-5. PubMed ID: 17299008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradigm for the management of patient outcomes.
    Gouveia WA; Bungay KM; Massaro FJ; Ware JE
    Am J Hosp Pharm; 1991 Sep; 48(9):1912-6. PubMed ID: 1928132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacists' and patients' roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script?
    Worley MM; Schommer JC; Brown LM; Hadsall RS; Ranelli PL; Stratton TP; Uden DL
    Res Social Adm Pharm; 2007 Mar; 3(1):47-69. PubMed ID: 17350557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of pharmacist presence on compliance with advanced cardiac life support guidelines during in-hospital cardiac arrest.
    Draper HM; Eppert JA
    Ann Pharmacother; 2008 Apr; 42(4):469-74. PubMed ID: 18349308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of pharmacists on the cancer chemotherapy].
    Inoue T
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):11-6. PubMed ID: 14750314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
    Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
    Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensuring optimal insulin utilization in the hospital setting: role of the pharmacist.
    Kelly JL
    Am J Health Syst Pharm; 2010 Aug; 67(16 Suppl 8):S9-16. PubMed ID: 20689152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.